GlassScriptPhysician profile
Marco Munoz
NPI 1356659585
$1,315.49
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $307 · 2021: $28.42 · 2022: $19.97 · 2023: $17.45 · 2024: $14.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $267.88 | 2019-2020 | |
| Novo Nordisk INC | $203.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $159.78 | 2019-2020 | |
| Amgen INC. | $157.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $87.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $86.15 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $64.49 | 2019-2020 | |
| Pfizer INC. | $40.50 | 2019 | |
| Genentech USA, INC. | $33.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.49 | 2019 | |
| Amarin Pharma, INC. | $28.90 | 2019-2020 | |
| Abbvie INC. | $28.42 | 2021 | |
| Phadia US INC. | $19.97 | 2022 | |
| Eisai INC. | $19.39 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.45 | 2023 | Dupixent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.06 | 2020 | |
| Exact Sciences Corporation | $14.15 | 2024 | Cologuard Collection Kit |
| Mission Pharmacal Company | $14.14 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.